We have a new investigational research study evaluating the dose response of once-weekly injection in patients with Type 2 Diabetes between 18 and 64 years of age.
The total study participation is approximately 1 year.
If qualified, you may be compensated up to $1,110.00 for your time and travel. You will also receive study related care at no cost.
Qualified participants must:
- Be a generally adult; 18-64 years of age
- Have a BMI ≥0 kg/m2
- Be diagnosed with Type 2 Diabetes
- Have an HbA1c between 7.0-10.5%